Back to Search
KALI STEVENS, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1194352641Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Comment on Ganzini and Dobscha regarding comparing rates of physician-assisted suicide in Oregon with that of other states.
PMID 15830565·J Clin Ethics·2004
4-observational
Effect of left-sided valvular regurgitation on mortality and causes of death among a population of middle-aged and older horses.
PMID 19122214·Vet Rec·2009
7-preclinical
The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood.
PMID 19394689·Biomaterials·2009
8-other
Scaffold-free human cardiac tissue patch created from embryonic stem cells.
PMID 19063661·Tissue Eng Part A·2009
8-other
Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R).
PMID 19101143·Bioorg Med Chem Lett·2009
7-preclinical
Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.
PMID 19208477·Bioorg Med Chem Lett·2009
4-observational
Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.
PMID 19394223·Bioorg Med Chem Lett·2009
8-other
Qualitative cost-benefit evaluation of complex, emergent programs.
PMID 19007990·Eval Program Plann·2009
8-other
Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: potent inhibitors of the IGF-1R receptor tyrosine kinase.
PMID 19056263·Bioorg Med Chem Lett·2009
7-preclinical
Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity.
PMID 19071018·Bioorg Med Chem Lett·2009
8-other
Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: elimination of an acid-mediated decomposition pathway.
PMID 19081716·Bioorg Med Chem Lett·2009
8-other
Furan-modified oligonucleotides for fast, high-yielding and site-selective DNA inter-strand cross-linking with non-modified complements.
PMID 19151089·Nucleic Acids Res·2009
8-other
Assessment of saccular function in children with sensorineural hearing loss.
PMID 19153306·Arch Otolaryngol Head Neck Surg·2009
8-other
Farm-level factors associated with above-average production on pig farms in Evia, Greece.
PMID 19356814·Prev Vet Med·2009
7-preclinical
Discharging patients from the nephrology clinic to primary care--will they get appropriate monitoring of renal function?
PMID 19376793·QJM·2009
8-other
The hydrophobic tunnel present in LOX-1 is essential for oxidized LDL recognition and binding.
PMID 18845619·J Lipid Res·2009
7-preclinical
Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivo.
PMID 18971326·Mol Pharmacol·2009
7-preclinical
Reductions in disability prevalence among the highest income groups of older Brazilians.
PMID 19008509·Am J Public Health·2009
8-other
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.
PMID 19028424·Bioorg Med Chem Lett·2009
7-preclinical
In vitro comparison of bacterial contamination of peripheral intravenous catheter connectors.
PMID 19411685·Vet Rec·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11100 EUCLID AVE
CLEVELAND, OH 44106 - Phone
- (603) 724-0088
Quick Facts
- NPI
- 1194352641
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile